APA (7th ed.) Citation

Massa, C., Karn, T., Weber, K., Schneeweiss, A., Hanusch, C. A., Blohmer, J., . . . Seliger, B. (2024). Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients: Letter to the journal. Clinical and translational medicine, 14(4), . https://doi.org/10.1002/ctm2.1617

Chicago Style (17th ed.) Citation

Massa, Chiara, et al. "Baseline CD4+ and Expansion of γδ T Cells Correlate with Response to Durvalumab in Triple-negative Breast Cancer Patients: Letter to the Journal." Clinical and Translational Medicine 14, no. 4 (2024). https://doi.org/10.1002/ctm2.1617.

MLA (9th ed.) Citation

Massa, Chiara, et al. "Baseline CD4+ and Expansion of γδ T Cells Correlate with Response to Durvalumab in Triple-negative Breast Cancer Patients: Letter to the Journal." Clinical and Translational Medicine, vol. 14, no. 4, 2024, https://doi.org/10.1002/ctm2.1617.